GGrantIndex
← Leaderboards

James William Gaynor

Children'S Hosp Of Philadelphia

$5,405,569
Attributed
$8,904,036
Total exposure
3
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $770.7K · FY200523
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$8,904,036 · 3

By mechanism

R01$3,656,336 · 1
U10$2,660,500 · 1
UG1$2,587,200 · 1

Top collaborators

Most similar at Children'S Hosp Of Philadelphia

Same institution · by research overlap

Others in their field

Top investigators on “Child

Research focus

ChildProgramsHeartAffectChildhoodProspectiveCongenital Heart DisorderClinical ResearchCardiacEnrollmentInstitutionCardiovascular SystemInfantHeart DiseasesCommon VentricleHeart ResearchInnovationGenderGrantDiscipline Of NursingFunding OpportunitiesFutureDatabasesClinical Trials

Grant awards (18)

Pediatric Heart Network Children's Hospital of Philadelphia$369,600
UG1 · FY2023 · HL
Pediatric Heart Network Children's Hospital of Philadelphia$369,600
UG1 · FY2022 · HL
Pediatric Heart Network Children's Hospital of Philadelphia$369,600
UG1 · FY2021 · HL
Pediatric Heart Network Children's Hospital of Philadelphia$369,600
UG1 · FY2020 · HL
Pediatric Heart Network Children's Hospital of Philadelphia$369,600
UG1 · FY2019 · HL
Pediatric Heart Network Children's Hospital of Philadelphia$369,600
UG1 · FY2018 · HL
Pediatric Heart Network Children's Hospital of Philadelphia$369,600
UG1 · FY2017 · HL
Sidenafil Impacts Exercise Performance in Adolescent Survivors of the Fontan$502,500
U10 · FY2015 · HL
Sidenafil Impacts Exercise Performance in Adolescent Survivors of the Fontan$502,500
U10 · FY2014 · HL
Sidenafil Impacts Exercise Performance in Adolescent Survivors of the Fontan$502,500
U10 · FY2013 · HL
Sidenafil Impacts Exercise Performance in Adolescent Survivors of the Fontan$148,000
U10 · FY2013 · HL
Sidenafil Impacts Exercise Performance in Adolescent Survivors of the Fontan$502,500
U10 · FY2012 · HL
Sidenafil Impacts Exercise Performance in Adolescent Survivors of the Fontan$502,500
U10 · FY2011 · HL
APOE Genotype and Sequelae of Infant Cardiac Surgery$705,432
R01 · FY2007 · HL · contact PI
APOE Genotype and Sequelae of Infant Cardiac Surgery$749,952
R01 · FY2006 · HL · contact PI
APOE Genotype and Sequelae of Infant Cardiac Surgery$770,693
R01 · FY2005 · HL
APOE Genotype and Sequelae of Infant Cardiac Surgery$720,478
R01 · FY2004 · HL
APOE Genotype and Sequelae of Infant Cardiac Surgery$709,781
R01 · FY2003 · HL